Literature DB >> 2141796

Release of atrial natriuretic peptide from rat myocardium in vitro: effect of minoxidil-induced hypertrophy.

P Kinnunen1, T Taskinen, J Leppäluoto, H Ruskoaho.   

Abstract

1. Ventricular hypertrophy is characterized by stimulation of ventricular synthesis of atrial natriuretic peptide (ANP). To examine the role of ventricular ANP levels in the secretion of ANP into the circulation, atrial and ventricular levels of immunoreactive-ANP (IR-ANP) as well as ANP messenger RNA (mRNA), and the release of IR-ANP from isolated perfused hearts, both before and after atrialectomy, were measured simultaneously in control and minoxidil-treated Wistar-Kyoto (WKY) and spontaneously hypertensive (SHR) rats. 2. IR-ANP levels in the ventricles of untreated, 12 month-old SHR with severe ventricular hypertrophy were increased when compared to age-matched WKY rats. Minoxidil treatment for 8 weeks in both strains resulted in a decrease in mean arterial pressure and increases in ventricular weight to body weight ratios, plasma IR-ANP concentrations (in WKY from 133 +/- 20 to 281 +/- 34 pg ml-1, P less than 0.01; in SHR from 184 +/- 38 to 339 +/- 61 pg ml-1, P less than 0.05), and in ventricular IR-ANP contents (in WKY: 53%; in SHR: 41%). A highly significant correlation was found between ventricular IR-ANP content and ventricular weight to body weight ratio (r = 0.59, P less than 0.001, n = 26). 3. When studied in vitro, in isolated perfused heart preparations, the hypertrophied ventricular tissue after atrialectomy secreted more ANP into the perfusate than ventricles of the control hearts; ventricles contributed 28%, 22%, 18% and 15% of the total ANP release to perfusate in the minoxidil-treated SHR, control SHR, minoxidil-treated WKY and control WKY, respectively. A significant correlation was found between the IR-ANP release from ventricles and ventricular weight to body weight ratio (r = 0.56, P < 0.01, n = 24). 4. These studies demonstrate that the ventricles contribute substantially to the circulating level of ANP, and that the amount released depends on the degree of ventricular hypertrophy.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2141796      PMCID: PMC1917530          DOI: 10.1111/j.1476-5381.1990.tb12992.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  36 in total

Review 1.  The heart and the atrial natriuretic factor.

Authors:  M Cantin; J Genest
Journal:  Endocr Rev       Date:  1985       Impact factor: 19.871

2.  Extra-atrial expression of the gene for atrial natriuretic factor.

Authors:  D G Gardner; C F Deschepper; W F Ganong; S Hane; J Fiddes; J D Baxter; J Lewicki
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

3.  Increase in atrial pressure releases atrial natriuretic peptide from isolated perfused rat hearts.

Authors:  H Ruskoaho; H Thölken; R E Lang
Journal:  Pflugers Arch       Date:  1986-08       Impact factor: 3.657

4.  George E. Brown memorial lecture. Role of atrial peptides in body fluid homeostasis.

Authors:  B J Ballermann; B M Brenner
Journal:  Circ Res       Date:  1986-05       Impact factor: 17.367

5.  Serum noradrenaline response to standing up in patients with Parkinson's disease.

Authors:  J T Turkka; K K Juujärvi; T O Lapinlampi; V V Myllylä
Journal:  Eur Neurol       Date:  1986       Impact factor: 1.710

Review 6.  Regression of cardiac hypertrophy with drug treatment in spontaneously hypertensive rats.

Authors:  H Ruskoaho
Journal:  Med Biol       Date:  1984

7.  Alignment of rat cardionatrin sequences with the preprocardionatrin sequence from complementary DNA.

Authors:  T G Flynn; P L Davies; B P Kennedy; M L de Bold; A J de Bold
Journal:  Science       Date:  1985-04-19       Impact factor: 47.728

8.  Regulation of ventricular atrial natriuretic peptide release in hypertrophied rat myocardium. Effects of exercise.

Authors:  H Ruskoaho; P Kinnunen; T Taskinen; O Vuolteenaho; J Leppäluoto; T E Takala
Journal:  Circulation       Date:  1989-08       Impact factor: 29.690

9.  Atrial natriuretic peptide mRNA is regulated by glucocorticoids in vivo.

Authors:  D G Gardner; S Hane; D Trachewsky; D Schenk; J D Baxter
Journal:  Biochem Biophys Res Commun       Date:  1986-09-30       Impact factor: 3.575

10.  Neonatal atria and ventricles secrete atrial natriuretic factor via tissue-specific secretory pathways.

Authors:  K D Bloch; J G Seidman; J D Naftilan; J T Fallon; C E Seidman
Journal:  Cell       Date:  1986-12-05       Impact factor: 41.582

View more
  3 in total

1.  Hypertrophic phenotype in cardiac cell assemblies solely by structural cues and ensuing self-organization.

Authors:  Chiung-yin Chung; Harold Bien; Eric A Sobie; Vikram Dasari; David McKinnon; Barbara Rosati; Emilia Entcheva
Journal:  FASEB J       Date:  2010-11-17       Impact factor: 5.191

2.  Quinapril treatment and arterial smooth muscle responses in spontaneously hypertensive rats.

Authors:  P Arvola; H Ruskoaho; H Wuorela; A Pekki; H Vapaatalo; I Pörsti
Journal:  Br J Pharmacol       Date:  1993-04       Impact factor: 8.739

3.  Effect of phorbol ester on the release of atrial natriuretic peptide from the hypertrophied rat myocardium.

Authors:  P Kinnunen; T Taskinen; M Järvinen; H Ruskoaho
Journal:  Br J Pharmacol       Date:  1991-02       Impact factor: 8.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.